A synthetic biology approach to analyze evolution of programmed bacterial death Programmed death is commonly associated with a bacterial response to stressful conditions, such as starvation, presence of competitors, and antibiotic treatment. As death offers no benefit to its actor, evolution of programmed bacterial death is a fundamental, unresolved problem in biology. A popular explanation is that the death is altruistic: it can provide direct or indirect benefitsto the survivors. In other words, death may represent the ultimate form of cooperation. By making this assumption, evolution of programmed death can be analyzed under the general framework of public-good cooperation. Using this framework, studies have suggested possible public goods resulting from death in various bacterial pathogens. However, there remains a fundamental gap in the definitive understanding of microbial social behavior in general and programmed bacterial death in particular. Indeed, advantage of altruistic death has never been unequivocally demonstrated in an experimental system. A major challenge in tackling this problem is the complexity of natural biological processes, where numerous confounding factors obscure interpretation and quantitative analysis of the benefits associated with death. For example, previous work has been criticized because gene manipulations involved led to multiple effects and so it is hard to tease apart different fitness consequences. These issues make the results open to alternative explanations, such as PCD representing a maladaptive response to stress. We propose to use a combination of synthetic-biology techniques and microfluidics to overcome these limitations. In particular, using a set of synthetic gene circuits in bacterium Escherichia coli to implement tunable altruistic death, we will quantitatively define the condition under which altruistic death can become advantageous at the population level and examine their evolutionary dynamics in the presence of cheating. To enable such analysis, we will develop a novel droplet-based platform to examine the evolutionary dynamics under different conditions. Building on such understanding, we will develop and evaluate new treatment strategies that will exploit the evolutionary dynamics. It is our vision that the proposed research will have several broad impacts. First, it will fill the critical conceptual gap in our understandig of the evolution of programmed death. Second, it will generate novel insights into how bacteria respond to antibiotic-mediated stress, which has implications for designing novel therapeutic strategies against bacterial pathogens.
to Public Health The proposed research approach will provide insights into evolution of bacterial cooperation, which is critical for development and virulence of bacterial pathogens. Furthermore, it will develop and evaluate of novel, effective treatment strategies against two clinically relevant pathogens.
| Lee, Anna J; Wang, Shangying; Meredith, Hannah R et al. (2018) Robust, linear correlations between growth rates and ?-lactam-mediated lysis rates. Proc Natl Acad Sci U S A 115:4069-4074 |
| Wang, Hong-Xia; Song, Ziyuan; Lao, Yeh-Hsing et al. (2018) Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide. Proc Natl Acad Sci U S A 115:4903-4908 |
| Li, Mingqiang; Jiang, Weiqian; Chen, Zaozao et al. (2017) A versatile platform for surface modification of microfluidic droplets. Lab Chip 17:635-639 |
| Srimani, Jaydeep K; Huang, Shuqiang; Lopatkin, Allison J et al. (2017) Drug detoxification dynamics explain the postantibiotic effect. Mol Syst Biol 13:948 |
| Chan, H F; Ma, S; Tian, J et al. (2017) High-throughput screening of microchip-synthesized genes in programmable double-emulsion droplets. Nanoscale 9:3485-3495 |
| Lee, Jaewoo; Jackman, Jennifer G; Kwun, Jean et al. (2017) Nucleic acid scavenging microfiber mesh inhibits trauma-induced inflammation and thrombosis. Biomaterials 120:94-102 |
| Wu, Feilun; Bethke, Jonathan H; Wang, Meidi et al. (2017) Quantitative and synthetic biology approaches to combat bacterial pathogens. Curr Opin Biomed Eng 4:116-126 |
| Ji, HaYeun; Kim, Hye Sung; Kim, Hae-Won et al. (2017) Application of induced pluripotent stem cells to model smooth muscle cell function in vascular diseases. Curr Opin Biomed Eng 1:38-44 |
| Tanouchi, Yu; Pai, Anand; Park, Heungwon et al. (2017) Long-term growth data of Escherichia coli at a single-cell level. Sci Data 4:170036 |
| Lopatkin, Allison J; Meredith, Hannah R; Srimani, Jaydeep K et al. (2017) Persistence and reversal of plasmid-mediated antibiotic resistance. Nat Commun 8:1689 |
Showing the most recent 10 out of 21 publications
